• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺鳞状细胞癌的肿瘤微环境——组织学和免疫组织化学研究

Tumor microenvironment in squamous cell lung cancer - histological and immunohistochemical study.

作者信息

Cîmpeanu Ovidiu Lucian, Osman Andrei, Georgescu Alina Maria, Andrei Elena Cristina, Oprea Bogdan, Mateescu Valentin Octavian, Pătru Larisa, Mogoantă Carmen Aurelia, Tănase Ionuţ, Ciocâlteu Adriana Mihaela, Iovănescu Dan, Liliac Ilona Mihaela, Olteanu Mihai, Streba Costin Teodor

机构信息

Department of Histology, University of Medicine and Pharmacy of Craiova, Romania;

出版信息

Rom J Morphol Embryol. 2025 Jan-Mar;66(1):153-161. doi: 10.47162/RJME.66.1.14.

DOI:10.47162/RJME.66.1.14
PMID:40384201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12236294/
Abstract

Globally, lung cancer is the primary cause of cancer-related mortality. Squamous cell carcinoma (SCC) of the lung, a subtype of non-small cell lung cancer (NSCLC), accounts for a significant portion of new cases and is primarily associated with smoking and environmental pollutants. This study investigates the histopathological and immunohistochemical (IHC) characteristics of the tumor microenvironment (TME) in SCC using tissue samples from 19 patients who underwent surgery for lung cancer. IHC markers, including cluster of differentiation (CD)68, CD3 and CD34 were used to assess various components of the TME, including immune cell infiltration, and angiogenesis. The results revealed significant presence of macrophages, T-lymphocytes, and myofibroblasts, as well as increased vascularization in the tumor stroma. These findings highlight the complex interaction between tumor cells and the surrounding stroma, contributing to tumor progression. Understanding these mechanisms is crucial for improving early diagnosis and therapeutic strategies for SCC.

摘要

在全球范围内,肺癌是癌症相关死亡的主要原因。肺鳞状细胞癌(SCC)是非小细胞肺癌(NSCLC)的一种亚型,占新发病例的很大一部分,主要与吸烟和环境污染物有关。本研究使用19例接受肺癌手术患者的组织样本,调查SCC中肿瘤微环境(TME)的组织病理学和免疫组织化学(IHC)特征。使用免疫组织化学标志物,包括分化簇(CD)68、CD3和CD34来评估TME的各种成分,包括免疫细胞浸润和血管生成。结果显示肿瘤基质中存在大量巨噬细胞、T淋巴细胞和成肌纤维细胞,以及血管生成增加。这些发现突出了肿瘤细胞与周围基质之间的复杂相互作用,促进了肿瘤进展。了解这些机制对于改善SCC的早期诊断和治疗策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/1c91c74eed3b/RJME-66-1-153-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/88b3ebc5790a/RJME-66-1-153-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/94a3129469ef/RJME-66-1-153-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/d892bfc5090b/RJME-66-1-153-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/87b6ce6dccc4/RJME-66-1-153-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/7ce63666b0a6/RJME-66-1-153-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/3f3259b8b2bc/RJME-66-1-153-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/5e7bde1f83bc/RJME-66-1-153-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/9c99d6c62003/RJME-66-1-153-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/4d7fc5532ea1/RJME-66-1-153-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/c62e483a9565/RJME-66-1-153-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/b2de287175fb/RJME-66-1-153-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/aa769ff0af8e/RJME-66-1-153-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/1c91c74eed3b/RJME-66-1-153-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/88b3ebc5790a/RJME-66-1-153-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/94a3129469ef/RJME-66-1-153-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/d892bfc5090b/RJME-66-1-153-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/87b6ce6dccc4/RJME-66-1-153-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/7ce63666b0a6/RJME-66-1-153-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/3f3259b8b2bc/RJME-66-1-153-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/5e7bde1f83bc/RJME-66-1-153-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/9c99d6c62003/RJME-66-1-153-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/4d7fc5532ea1/RJME-66-1-153-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/c62e483a9565/RJME-66-1-153-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/b2de287175fb/RJME-66-1-153-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/aa769ff0af8e/RJME-66-1-153-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b7/12236294/1c91c74eed3b/RJME-66-1-153-fig13.jpg

相似文献

1
Tumor microenvironment in squamous cell lung cancer - histological and immunohistochemical study.肺鳞状细胞癌的肿瘤微环境——组织学和免疫组织化学研究
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):153-161. doi: 10.47162/RJME.66.1.14.
2
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会国际多学科肺腺癌分类。
J Thorac Oncol. 2011 Feb;6(2):244-85. doi: 10.1097/JTO.0b013e318206a221.
3
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
4
Attenuated immune surveillance during squamous cell transformation of pancreatic adenosquamous cancer defines new therapeutic opportunity for cancer interception.胰腺腺鳞癌鳞状细胞转化过程中免疫监视功能减弱为癌症拦截提供了新的治疗机会。
J Immunother Cancer. 2025 Jun 23;13(6):e012066. doi: 10.1136/jitc-2025-012066.
5
Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer.非小细胞肺癌中肿瘤内中性粒细胞与淋巴细胞比值与循环中性粒细胞与淋巴细胞比值呈正相关。
J Immunother Cancer. 2025 Jun 24;13(6):e011458. doi: 10.1136/jitc-2025-011458.
6
Systemic treatment patterns and adherence to guidelines in Japanese patients with metastatic non-small cell lung cancer.日本转移性非小细胞肺癌患者的系统治疗模式及对指南的依从性
Future Oncol. 2025 Apr;21(9):1101-1111. doi: 10.1080/14796694.2025.2470611. Epub 2025 Feb 28.
7
Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.口腔鳞状细胞癌中m6A/m1A/m5C/m7G/ac4C修饰基因的生物信息学鉴定与验证
BMC Cancer. 2025 Jul 1;25(1):1055. doi: 10.1186/s12885-025-14216-7.
8
[Predictive Value of miRNAs Markers for Advanced Lung Squamous Cell Carcinoma].[微小RNA标志物对晚期肺鳞状细胞癌的预测价值]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):325-333. doi: 10.3779/j.issn.1009-3419.2025.102.16.
9
Clinicopathological features and reclassification of penile squamous cell carcinoma according to WHO classification 2022 for penile carcinoma with p16 immunohistochemical expression and its prognostic impact.阴茎鳞状细胞癌的临床病理特征及根据2022年世界卫生组织阴茎癌分类进行的重新分类,包括p16免疫组化表达情况及其预后影响。
Diagn Pathol. 2025 Jul 3;20(1):80. doi: 10.1186/s13000-025-01676-5.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
The combination of Shenhuang plaster and paclitaxel inhibits lung metastasis in breast cancer via modulation of the tumor microenvironment.神黄膏与紫杉醇联合应用通过调节肿瘤微环境抑制乳腺癌肺转移。
Front Oncol. 2025 Feb 28;15:1531493. doi: 10.3389/fonc.2025.1531493. eCollection 2025.
2
Metabolic pathway activation and immune microenvironment features in non-small cell lung cancer: insights from single-cell transcriptomics.非小细胞肺癌中的代谢途径激活与免疫微环境特征:来自单细胞转录组学的见解
Front Immunol. 2025 Feb 28;16:1546764. doi: 10.3389/fimmu.2025.1546764. eCollection 2025.
3
Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy.
肺腺癌与肺鳞状细胞癌的差异:驱动基因、治疗靶点及临床疗效
Genes Dis. 2024 Jul 11;12(3):101374. doi: 10.1016/j.gendis.2024.101374. eCollection 2025 May.
4
Mediates Immunosuppression of the Tumor Microenvironment in Non-Small Cell Lung Cancer.介导非小细胞肺癌肿瘤微环境的免疫抑制作用。
J Inflamm Res. 2025 Mar 8;18:3333-3347. doi: 10.2147/JIR.S509316. eCollection 2025.
5
Lung Cancer-Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature).肺癌——流行病学、发病机制、治疗及分子层面(文献综述)
Int J Mol Sci. 2025 Feb 26;26(5):2049. doi: 10.3390/ijms26052049.
6
Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression.致癌突变与肿瘤微环境:非小细胞肺癌进展的驱动因素
Cancers (Basel). 2025 Mar 1;17(5):853. doi: 10.3390/cancers17050853.
7
Comprehensive insights into Pindborg tumor: etiology, advanced diagnostic approaches, and evidence-based management strategies - review of literature.关于平博肿瘤的综合见解:病因、先进诊断方法及循证管理策略——文献综述
Rom J Morphol Embryol. 2024 Oct-Dec;65(4):617-625. doi: 10.47162/RJME.65.4.08.
8
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.膀胱癌:免疫疗法与盆腔淋巴结清扫术
Vaccines (Basel). 2024 Jan 31;12(2):150. doi: 10.3390/vaccines12020150.
9
Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review.癌细胞的黏附、转移与抑制:全面综述。
Mol Biol Rep. 2024 Jan 22;51(1):165. doi: 10.1007/s11033-023-08920-5.
10
Advances and challenges in the treatment of lung cancer.肺癌治疗的进展与挑战。
Biomed Pharmacother. 2023 Dec 31;169:115891. doi: 10.1016/j.biopha.2023.115891. Epub 2023 Nov 16.